RESPONSE BIOMEDICAL CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 12 rows in 2014. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2014-11-14: Reporting owner Kinnaird-Steen Barbara; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2014-03-20: Reporting owner Adams William J.; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2014-03-20: Reporting owner PURVIN JEFFREY L; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2014-03-20: Reporting owner Shannon Timothy Patrick; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2014-11-14 | Kinnaird-Steen Barbara Officer (Chief Operating Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 25,000 owned after | $0.88 exercise price | 2014-11-18 | |
| 2014-03-20 | Adams William J. Officer (CFO & Corporate Secretary) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +69,000 69,000 owned after | $1.50 exercise price | 2014-03-24 | |
| 2014-03-20 | PURVIN JEFFREY L Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +90,000 90,000 owned after | $1.50 exercise price | 2014-03-24 | |
| 2014-03-20 | Shannon Timothy Patrick Officer (SrVPWorldWideSales&Marketing) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +52,000 52,000 owned after | $1.50 exercise price | 2014-03-24 | |
| 2014-03-20 | Kinnaird-Steen Barbara Officer (Vice President) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +44,000 44,000 owned after | $1.50 exercise price | 2014-03-24 | |
| 2014-03-19 | SEVERSON CLINTON Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $1.43 exercise price | 2014-03-21 | |
| 2014-03-19 | KEEGAN JOSEPH D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $1.43 exercise price | 2014-03-21 | |
| 2014-03-19 | Shuster Lewis Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $1.43 exercise price | 2014-03-21 | |
| 2014-03-19 | Thompson Peter A. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $1.43 exercise price | 2014-03-21 | |
| 2014-03-19 | HOLLER ANTHONY F Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $1.43 exercise price | 2014-03-21 | |
| 2014-03-19 | Wang David Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $1.43 exercise price | 2014-03-21 | |
| 2014-03-19 | Wang Jonathan Jian Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $1.43 exercise price | 2014-03-21 |